Taku Yokoyama
Overview
Explore the profile of Taku Yokoyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
133
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Effect of renin-angiotensin system inhibitors in patients with cancer treated with anti-VEGF therapy
Moriyama S, Hieda M, Kisanuki M, Kawano S, Yokoyama T, Fukata M, et al.
Open Heart
. 2023 Jan;
9(2).
PMID: 36600585
Background: Cancer treatment with vascular endothelial growth factor signalling pathway (VSP) inhibitors frequently causes hypertension. Although previous reports suggested that the antihypertensive drug renin-angiotensin system inhibitor (RASI) may have a...
2.
Moriyama S, Hieda M, Kisanuki M, Kawano S, Yokoyama T, Fukata M, et al.
Circ J
. 2022 Dec;
88(2):217-225.
PMID: 36476830
Background: Hypertension is a frequent adverse event caused by vascular endothelial growth factor signaling pathway (VSP) inhibitors. However, the impact of hypertension on clinical outcomes during VSP inhibitor therapy remains...
3.
Fukudome Y, Hieda M, Masui S, Yokoyama T, Futami S, Moriyama S, et al.
Front Cardiovasc Med
. 2022 Jun;
9:915876.
PMID: 35711360
A 31-year-old woman was referred to our hospital for evaluation of a cardiac mass in the right atrium. Cardiac magnetic resonance imaging indicated a cystic mass filled with fluid accumulation...
4.
Moriyama S, Fukata M, Hieda M, Yokoyama T, Yoshimoto G, Kusaba H, et al.
Open Heart
. 2022 May;
9(1).
PMID: 35606045
Objective: Heart failure following allogeneic haematopoietic stem cell transplantation (allo-HSCT) is a serious complication that requires early detection; however, the clinical implications of early-onset cancer therapy-related cardiac dysfunction (CTRCD) following...
5.
Moriyama S, Fukata M, Yokoyama T, Ueno S, Nunomura T, Mori Y, et al.
Front Cardiovasc Med
. 2022 Apr;
9:848091.
PMID: 35387436
Case Summary: A 59-year-old man with refractory diffuse large B-cell lymphoma underwent CAR-T cell therapy. Grade 2 CRS was observed on day 0; it progressed to grade 4 on day...
6.
Moriyama S, Yokoyama T, Tsuchihashi K, Fukata M
Intern Med
. 2022 Feb;
61(19):2987-2988.
PMID: 35185057
No abstract available.
7.
Saiki C, Kashiwado Y, Yokoyama T, Ayano M, Imabayashi K, Kawano S, et al.
Mod Rheumatol Case Rep
. 2022 Feb;
6(2):183-188.
PMID: 35134204
A 25-year-old woman was admitted to our hospital with severe pulmonary arterial hypertension associated with systemic lupus erythematosus (SLE-PAH). Her mean pulmonary arterial pressure was 56 mmHg, and her SLE...
8.
Arita T, Maruyama T, Yokoyama T, Hieda M, Fukata M, Fujino T, et al.
Clin Hemorheol Microcirc
. 2020 May;
76(1):73-83.
PMID: 32417767
Background: Disturbed microcirculation is related to diabetic complications, and erythrocyte deformability is a critical factor regulating microcirculation. Objectives: To know the relationship between the impaired deformability and density profile in...
9.
Moriyama S, Yokoyama T, Irie K, Ito M, Tsuchihashi K, Fukata M, et al.
J Cardiol Cases
. 2019 Nov;
20(5):183-186.
PMID: 31719941
Fluorouracil (5-FU), a commonly used anticancer agent, has potent cardiotoxicity that is mediated by vascular endothelial injury and vasospasm. Here, we report a patient demonstrating atrial fibrillation (AF), which was...
10.
Yasuda S, Fukata M, Yokoyama T, Arita T, Odashiro K, Maruyama T, et al.
Intern Med
. 2018 Nov;
58(6):809-812.
PMID: 30449782
A 58-year-old woman complained of general fatigue and was diagnosed with sick sinus syndrome (SSS) by ambulatory electrocardiogram, which demonstrated sinus arrest at midnight and paroxysmal atrial fibrillation (AF) at...